Clinical Trial Update: Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating rivaroxaban estimation with warfarin in atrial fibrillation patients with coronary stent implantation (REWRAPS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Coronary Artery Disease

Drugs mentioned

• Rivaroxaban (rivaroxaban)
• Warfarin (warfarin)

Snippet

Sponsor: Fujita Health University | Conditions: Coronary Artery Disease, Atrial Fibrillation | Phase 4 | Status: COMPLETED